Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Analyst Ratings for Marathon Oil A Mixed Bag of Opinions

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Ev clean energy
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Financial experts have been closely examining Marathon Oil (NYSE: MRO) and their findings have ranged from optimistic to pessimistic. Over the past month, there have been 16 Buy Ratings, 3 Hold Ratings, and 1 Sell Rating for MRO. The average price target for Marathon Oil stands at $31.06, with a high estimate of $39.00 and a low estimate of $25.00.

Analyst actions have been varied, with Roger Read from Wells Fargo upgrading the rating to Overweight with a price target of $36.00, while Josh Silverstein from UBS downgraded the rating to Neutral with a price target of $27.00. Overall, Marathon Oil holds a consensus rating of Moderate Buy, based on 12 buy ratings, 3 hold ratings, and 1 sell rating.

Analysts frequently adjust their recommendations based on market conditions and company performance, providing valuable insights into Marathon Oil’s current standing. By considering these analyst evaluations alongside key financial indicators, investors can gain a better understanding of Marathon Oil’s market position.

In conclusion, Marathon Oil’s stock ratings reflect a range of opinions from analysts, with recent adjustments indicating shifting sentiments towards the company’s performance and future outlook.

Marathon Oil Corporation (MRO) Shows Positive Price Momentum on March 12, 2024

On March 12, 2024, Marathon Oil Corporation (MRO) showed positive price momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of MRO shares increased by $0.13 since the market last closed, representing a 0.52% rise.

The stock opened at $24.96, which was $0.03 lower than its previous close. Despite the slight dip in the opening price, MRO managed to recover and show a positive price movement throughout the trading day. This indicates that investors were optimistic about the company’s performance and potential for growth.

Marathon Oil Corporation is a leading energy company that focuses on exploration, production, and marketing of oil and natural gas. As a key player in the energy sector, MRO’s stock performance is closely monitored by investors and analysts alike.

The positive price momentum on March 12th could be attributed to a variety of factors, including overall market conditions, industry trends, and company-specific news. Investors may have been encouraged by positive developments within the energy sector or favorable economic indicators that could impact MRO’s business operations.

Marathon Oil Corporation (MRO) Financial Performance Review: Disappointing Results Raise Concerns

On March 12, 2024, investors in Marathon Oil Corporation (MRO) may have been disappointed to see the company’s stock performance in light of the latest financial data released. According to CNN Money, Marathon Oil reported a total revenue of $6.41 billion for the past year, a decrease of 15.03% compared to the previous year. Additionally, the total revenue for the fourth quarter was $1.58 billion, down 10.5% from the previous quarter.

The net income for Marathon Oil was reported at $1.55 billion for the past year, a significant decrease of 56.98% compared to the previous year. The net income for the fourth quarter was $397.00 million, down 12.36% from the previous quarter. This decline in net income may have raised concerns among investors about the company’s profitability and financial health.

Earnings per share (EPS) for Marathon Oil were reported at $2.56 for the past year, a decrease of 51.39% compared to the previous year. The EPS for the fourth quarter was $0.68, holding flat compared to the previous quarter. While the EPS remained steady for the quarter, the significant decrease in EPS for the past year may have contributed to a negative sentiment among investors.

Overall, the financial data released by Marathon Oil on March 12, 2024, painted a mixed picture of the company’s performance. The decline in total revenue, net income, and EPS may have raised concerns among investors about the company’s ability to generate profits and sustain growth. As a result, Marathon Oil’s stock performance on that day may have been affected by the disappointing financial results. Investors may want to closely monitor the company’s future financial reports and performance to assess its long-term prospects in the market.

Tags: MRO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Blockchain Stock Market Today

Oracles AI Revolution Hypergrowth and Market Success

Logistics Markets and money

Title Postage Policy Guidelines and Collaboration Process

Analyst Outlook on Elanco Animal Health Neutral Rating with 18 Price Target

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com